Diabetes Reversal and the Subgingival Microbiota
NCT05501093 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102
Last updated 2026-03-19
Summary
This study seeks to examine the impact of bariatric surgery on oral bacteria in diabetic compared to non-diabetic patients. The purpose of this research study is to examine how diabetes changes the bacteria in the mouth. This is an important question since bacterial changes may impact oral health. Participants will attend a screening and baseline visit prior to bariatric surgery and three post bariatric surgery appointments (3 weeks post, 6 months post and 1 year to 18 months post). Samples collected at each study visit include blood, plaque, and other oral samples. At the last study visit there is an optional dental cleaning.
Conditions
- Diabetes type2
- Bariatric Surgery Candidate
Interventions
- OTHER
-
sample collection
Blood, plaque, and other oral samples
Sponsors & Collaborators
-
National Institute of Dental and Craniofacial Research (NIDCR)
collaborator NIH -
Temple University
collaborator OTHER -
Ohio State University
collaborator OTHER - lead OTHER
Principal Investigators
-
Dana Graves, DDS, DMSc · University of Pennsylvania
Eligibility
- Min Age
- 25 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-11
- Primary Completion
- 2025-06-30
- Completion
- 2025-06-30
Countries
- United States
Study Locations
More Related Trials
-
The Surgical Treatment of Type 2 Diabetes Mellitus in Non-Morbidly Obese Patients: A Community Hospital Study
NCT01323114 ·Status: UNKNOWN ·Phase: NA
-
Bariatric Surgery And Adipose Inflammation Dysfunction and Type 2 Diabetes Mellitus
NCT01882036 ·Status: COMPLETED ·Phase: NA
-
Effects of Bariatric Surgery on Insulin
NCT00535600 ·Status: COMPLETED
-
Longitudinal Phenotyping of Bariatric Surgery Patients
NCT02421055 ·Status: COMPLETED
-
Cardiovascular Outcomes in Bariatric Surgery Patients With Type 2 Diabetes
NCT03955952 ·Status: COMPLETED
-
The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 Diabetes
NCT02762708 ·Status: COMPLETED ·Phase: PHASE2
-
Diabetes and Gastric By- Pass
NCT01153516 ·Status: COMPLETED
-
Bariatric Surgery-Induced Shift in Gut Microbiome and NAFLD
NCT04263376 ·Status: COMPLETED
-
Medication Following Bariatric Surgery for Type 2 Diabetes Mellitus
NCT04432025 ·Status: RECRUITING ·Phase: NA
-
Endotoxin and Intestinal Flora Before and After Gastric Bypass or Banding in Diabetics
NCT00960765 ·Status: COMPLETED
-
Longitudinal Assessment of Bariatric Surgery Sub-Study
NCT02985853 ·Status: UNKNOWN
-
Extracellular Vesicle Cargo in Obesity and Type 2 Diabetes
NCT06401876 ·Status: COMPLETED
-
Effects of Medical and Surgical Weight Loss on Metabolism
NCT00592735 ·Status: COMPLETED
-
Intestinal Microbiota in Patients Before and After Bariatric Surgery and Healthy Controls
NCT02563119 ·Status: COMPLETED ·Phase: NA
-
FMT in Obesity: RYGB vs. LEAN vs. Autologous FMT
NCT06268990 ·Status: RECRUITING ·Phase: NA
-
Improving Diabetes Through Lifestyle and Surgery
NCT01667783 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Bariatric Surgery on Brain Insulin Sensitivity
NCT03705923 ·Status: TERMINATED ·Phase: NA
-
Biomarkers Derived From Adipose Tissue Useful for Diagnosis and Prognosis of Cardiovascular Risk (CVR) in Obese Patient
NCT03561987 ·Status: UNKNOWN
-
Effect of BAriatric Surgery Versus Optimal Medical Therapy on Cardiovascular Health and Atherosclerosis in Obese, Type II Diabetic Patients
NCT02331420 ·Status: UNKNOWN ·Phase: NA
-
Reversal of Obese/Diabetic Cardiomyopathy After Gastric Bypass Surgery
NCT01067209 ·Status: COMPLETED
-
Gut Microbiota in Metabolic Surgery
NCT05000996 ·Status: RECRUITING
-
Effect of Bariatric Surgery on Blood Pressure
NCT02050984 ·Status: UNKNOWN
-
Surgical Treatment of Non-obese Type 2 Diabetic Patients With Duodenal Exclusion
NCT00566358 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Fecal Microbiota Transfer to Improve Diabetes Control Post-bariatric Surgery
NCT06192693 ·Status: RECRUITING ·Phase: PHASE3
-
The Effects of Metabolic & Bariatric Surgery on Lipid Metabolism, Myeloid-Derived Suppressor Cells, and Cancer Cell Biology
NCT06059651 ·Status: RECRUITING